Literature DB >> 11166956

Differences in sensitivity of vanilloid receptor 1 transfected to human embryonic kidney cells and capsaicin-activated channels in cultured rat dorsal root ganglion neurons to capsaicin receptor agonists.

J S Shin1, M H Wang, S W Hwang, H Cho, S Y Cho, M J Kwon, S Y Lee, U Oh.   

Abstract

Heterologously expressed vanilloid receptor 1 (VR1), a cloned cDNA encoding for capsaicin (CAP)-sensitive currents, resembles the native CAP channels in cultured sensory neurons in channel property. But, the pharmacological profile of VR1 to various CAP analogs is not known. The stable expression of VR1 in human embryonic kidney (HEK) cells was generated and confirmed by reverse transcription-polymerase chain reaction and Western blots. VR1 expressed in HEK cells retained single-channel properties similar to those of the native channels. When concentration-response relationships were compared, CAP and DA-5018.HCl, a synthetic analog of CAP, exhibited a greater potency in activating VR1 than the native channels in sensory neurons. In contrast, resiniferatoxin and its analog, phorbol 12-phenylacetate 13-acetate 20-homovanillate, was more potent in activating the CAP-activated channels in cultured sensory neurons than VR1. Thus, the difference in pharmacological profiles of VR1 and the native channels suggests the possible presence of subtypes of the CAP receptor or regulatory mechanisms associated with VR1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166956     DOI: 10.1016/s0304-3940(00)01777-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.

Authors:  M Tominaga; M Wada; M Masu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 2.  Vanilloid receptor ligands: hopes and realities for the future.

Authors:  A Szallasi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry.

Authors:  Brian J Wisnoskey; William G Sinkins; William P Schilling
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

4.  The endoplasmic reticulum of dorsal root ganglion neurons contains functional TRPV1 channels.

Authors:  Sonia Gallego-Sandín; Arancha Rodríguez-García; María Teresa Alonso; Javier García-Sancho
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

5.  TRPV1 recapitulates native capsaicin receptor in sensory neurons in association with Fas-associated factor 1.

Authors:  Sangsung Kim; Changjoong Kang; Chan Young Shin; Sun Wook Hwang; Young Duk Yang; Won Sik Shim; Min-Young Park; Eunhee Kim; Misook Kim; Byung-Moon Kim; Hawon Cho; Youngki Shin; Uhtaek Oh
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

6.  Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.

Authors:  Louise A Roberts; MacDonald J Christie; Mark Connor
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cells.

Authors:  Lilian L Nohara; Hongjian Xu; Samuel Bertin; Yukari Aoki-Nonaka; Petrus Rudolf de Jong; Shawna R Stanwood; Sonal Srikanth; Jihyung Lee; Keith To; Lior Abramson; Timothy Yu; Tiffany Han; Ranim Touma; Xiangli Li; José M González-Navajas; Scott Herdman; Maripat Corr; Guo Fu; Hui Dong; Yousang Gwack; Alessandra Franco; Wilfred A Jefferies; Eyal Raz
Journal:  Nat Immunol       Date:  2014-10-05       Impact factor: 25.606

8.  Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins.

Authors:  Tomoko Moriyama; Tomohiro Higashi; Kazuya Togashi; Tohko Iida; Eri Segi; Yukihiko Sugimoto; Tomoko Tominaga; Shuh Narumiya; Makoto Tominaga
Journal:  Mol Pain       Date:  2005-01-17       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.